LBT Innovations applies for APAS patents
Friday, 16 March, 2012
LBT Innovations (ASX:LBT) has lodged multiple international patent applications for its Automated Plate Assessment System (APAS).
The technology, LBT Innovations' second automated diagnostics technology, automates the reading, reporting and sorting of culture plates.
The company lodged patents for the system under the Patent Cooperation Treaty. The system will now be examined by an international authority to ensure they meet standards of novelty and inventiveness.
LBT Innovations has now applied for 14 patent and design families associated with its two technologies. The company's first invention, PREVI Isola, automates the streaking of culture plates.
Patents associated with PREVI Isola have been granted in Australia, France, Germany, the United Kingdom, Italy, the Netherlands, Spain, New Zealand, China and the USA. Applications are also pending in further countries.
This technology has already been adopted by laboratories in the US, Australia, China, Japan, Korea, the Middle East, the UK and multiple European countries. LBT receives milestone and royalty payments for the device.
Adelaide-based LBT Innovations was founded in 2004, and listed on the ASX in July 2006. The company signed a deal with bioMérieux in 2007 to commercialise PREVI Isola.
LBT Innovations (ASX:LBT) shares stayed flat in Friday's trading to $0.054.
Proposed Australian trial eyes up blood testing for Alzheimer's
Utilising networks of GPs across three states, a large-scale study intends on combining digital...
Applications open for $300K pandemic therapeutics fellowships
Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...
